Non-alcoholic fatty liver induces insulin resistance and metabolic disorders with development of brain damage and dysfunction

In the present study we investigated the effect of the non-alcoholic fatty liver disease (NAFLD) on the alterations in the activity of neurotransmitters catabolizing enzymes and energy catabolising enzymes, prooxidants, endogenous antioxidants and proinflammatory cytokines in brain tissue of NAFLD rats. Rats were intraperitonealy injected with CCl4 solution at a dose of (0.021 mole/Kg, 20 μL, body weight) three times weekly for four weeks. Acetylcholine esterase (AChE), monoamine oxidase (MAO), prooxidant/ antioxidants status, ATPase, lipid profile and glucose level were estimated spectrophotometrically while inflammatory markers; interleukin 6 and tumor necrosis factor alpha (IL6 and TNF-α) and insulin were assessed by ELISA technique. Our results showed that the induced NAFLD and insulin resistance (IR) were accompanied with hyperglycemia and hyperlipidemia and lowered brain glucose level with elevated ATPase activity, prooxidant status (TBARS level, xanthine oxidase and cytochrome 2E1 activities), and inflammatory markers. Through the induction period AChE activity was significantly increased compared to control in blood, liver and brain tissues. Also, MAO activity was significantly increased in both brain and liver tissue but decreased in serum compared with control. These biochemical data were supported with pathophysiological analysis that showed severe neurodegeneration, pyknosis acuolations and cavitations. These observations warrant the reassessment of the conventional concept that the NAFLD with IR progression may induce disturbances in activities of neurotransmitters catabolising enzymes and energy production accompanied with oxidative stress and metabolic disorders, acting as relative risk factors for brain dysfunction and damage with the development of age-associated neurodegenerative diseases such as Alzheimer's disease.

[1]  A. Hofman,et al.  Non-insulin-dependent Diabetes Mellitus (niddm) Association of Diabetes Mellitus and Dementia: the Rotterdam Study , 2022 .

[2]  G. Shulman,et al.  Inhibition of protein kinase Cepsilon prevents hepatic insulin resistance in nonalcoholic fatty liver disease. , 2007, The Journal of clinical investigation.

[3]  L. Prencipe,et al.  Serum triglycerides determined colorimetrically with an enzyme that produces hydrogen peroxide. , 1982, Clinical chemistry.

[4]  H. Wood,et al.  A new, convenient method for the rapid analysis of inorganic pyrophosphate. , 1979, Analytical biochemistry.

[5]  G. Musso,et al.  Recent insights into hepatic lipid metabolism in non-alcoholic fatty liver disease (NAFLD). , 2009, Progress in lipid research.

[6]  Suzanne Craft,et al.  Insulin resistance syndrome and Alzheimer's disease: Age- and obesity-related effects on memory, amyloid, and inflammation , 2005, Neurobiology of Aging.

[7]  A. Diehl.  Nonalcoholic steatosis and steatohepatitis IV. Nonalcoholic fatty liver disease abnormalities in macrophage function and cytokines. , 2002, American journal of physiology. Gastrointestinal and liver physiology.

[8]  J. Bothwell,et al.  A colorimetric assay for xanthine oxidase in rat liver homogenates. , 1953, The Journal of biological chemistry.

[9]  L. Weber,et al.  Hepatotoxicity and Mechanism of Action of Haloalkanes: Carbon Tetrachloride as a Toxicological Model , 2003, Critical reviews in toxicology.

[10]  L. N. Valenti,et al.  Tumor necrosis factor alpha promoter polymorphisms and insulin resistance in nonalcoholic fatty liver disease. , 2002, Gastroenterology.

[11]  E. García-Arumí,et al.  Enhanced ROS production and antioxidant defenses in cybrids harbouring mutations in mtDNA , 2006, Neuroscience Letters.

[12]  Freya Q. Schafer,et al.  Nitric oxide as a cellular antioxidant: a little goes a long way. , 2006, Free radical biology & medicine.

[13]  J. Ward,et al.  Radioprotection of DNA by thiols: relationship between the net charge on a thiol and its ability to protect DNA. , 1988, Radiation research.

[14]  D. Befroy,et al.  Mechanism of Hepatic Insulin Resistance in Non-alcoholic Fatty Liver Disease* , 2004, Journal of Biological Chemistry.

[15]  S. Seki,et al.  In situ detection of lipid peroxidation and oxidative DNA damage in non-alcoholic fatty liver diseases. , 2002, Journal of hepatology.

[16]  B. Halliwell,et al.  Free radicals in biology and medicine , 1985 .

[17]  Division on Earth.  Guide for the Care and Use of Laboratory Animals , 1996 .

[18]  S. Shoelson,et al.  Local and systemic insulin resistance resulting from hepatic activation of IKK-beta and NF-kappaB. , 2005, Nature medicine.

[19]  Defective hepatic mitochondrial respiratory chain in patients with nonalcoholic steatohepatitis , 2003, Hepatology.

[20]  M. Hare,et al.  Tyramine oxidase: A new enzyme system in liver. , 1928, The Biochemical journal.

[21]  L. N. Valenti,et al.  Tumor necrosis factor α promoter polymorphisms and insulin resistance in nonalcoholic fatty liver disease , 2002 .

[22]  Janardan K. Reddy,et al.  III. Peroxisomal β-oxidation, PPARα, and steatohepatitis , 2001 .

[23]  C. Day,et al.  Steatohepatitis: a tale of two "hits"? , 1998, Gastroenterology.

[24]  S. Puri,et al.  Studies on the effects of monosodium glutamate on hepatic microsomal lipid peroxidation, calcium, ascorbic acid and glutathione and its dependent enzymes in adult male mice. , 1996, Toxicology letters.

[25]  D. Watson.  A simple method for the determination of serum cholesterol. , 1960, Clinica chimica acta; international journal of clinical chemistry.

[26]  D. Jollow,et al.  Bromobenzene-induced liver necrosis. Protective role of glutathione and evidence for 3,4-bromobenzene oxide as the hepatotoxic metabolite. , 1974, Pharmacology.

[27]  A. Pereiraa,et al.  ffects of strictosamide on mouse brain and kidney Na + , K +-ATPase and g 2 +-ATPase activities , 2008 .

[28]  J. Maher.  Alcoholic steatosis and steatohepatitis. , 2002, Seminars in gastrointestinal disease.

[29]  A. Gjedde,et al.  The metabolic role of isoleucine in detoxification of ammonia in cultured mouse neurons and astrocytes , 2007, Neurochemistry International.

[30]  Gabriele Siciliano,et al.  Cytochrome c oxidase and mitochondrial F1F0-ATPase (ATP synthase) activities in platelets and brain from patients with Alzheimer’s disease , 2002, Neurobiology of Aging.

[31]  R. Maccioni,et al.  Roles of Cholesterol and Lipids in the Etiopathogenesis of Alzheimer's Disease , 2006, Journal of biomedicine & biotechnology.

[32]  W. Valentine,et al.  Studies on the quantitative and qualitative characterization of erythrocyte glutathione peroxidase. , 1967, The Journal of laboratory and clinical medicine.

[33]  N. Zöllner,et al.  Über die quantitative Bestimmung von Lipoiden (Mikromethode) mittels der vielen natürlichen Lipoiden (allen bekannten Plasmalipoiden) gemeinsamen Sulfophosphovanillin-Reaktion , 1962 .

[34]  K. Cheng,et al.  Effect of cholinergic denervation on hepatic fibrosis induced by carbon tetrachloride in rats , 2008, Neuroscience Letters.

[35]  G. Marchesini,et al.  Nonalcoholic fatty liver, steatohepatitis, and the metabolic syndrome , 2003, Hepatology.

[36]  P. Hsu,et al.  Antioxidant nutrients and lead toxicity. , 2002, Toxicology.

[37]  Scott A Summers,et al.  Characterizing the effects of saturated fatty acids on insulin signaling and ceramide and diacylglycerol accumulation in 3T3-L1 adipocytes and C2C12 myotubes. , 2003, Archives of biochemistry and biophysics.

[38]  Fen Wang,et al.  Increased carbon tetrachloride-induced liver injury and fibrosis in FGFR4-deficient mice. , 2002, The American journal of pathology.

[39]  M. Beal,et al.  Mitochondria take center stage in aging and neurodegeneration , 2005, Annals of neurology.

[40]  A. Cederbaum,et al.  CYP2E1 overexpression inhibits microsomal Ca2+-ATPase activity in HepG2 cells. , 2009, Toxicology.

[41]  B. S. Mohammed,et al.  Liver, muscle, and adipose tissue insulin action is directly related to intrahepatic triglyceride content in obese subjects. , 2008, Gastroenterology.

[42]  S. Grundy,et al.  The metabolic syndrome. , 2008, Endocrine reviews.

[43]  A. Boschero,et al.  Involvement of the cholinergic pathway in glucocorticoid-induced hyperinsulinemia in rats. , 2010, Diabetes research and clinical practice.

[44]  A. Goldfine,et al.  Inflammation and insulin resistance. , 2006, The Journal of clinical investigation.

[45]  Karim Bouzakri,et al.  Tumor necrosis factor-alpha induces skeletal muscle insulin resistance in healthy human subjects via inhibition of Akt substrate 160 phosphorylation. , 2005, Diabetes.

[46]  I. Leclercq,et al.  themes Nonalcoholic Steatosis and Steatohepatitis II. Cytochrome P -450 enzymes and oxidative stress , 2001 .

[47]  L. Wilkins.  Intranasal insulin improves cognition and modulates β-amyloid in early AD , 2008, Neurology.

[48]  C. Lieber,et al.  Polyenylphosphatidylcholine prevents carbon tetrachloride-induced lipid peroxidation while it attenuates liver fibrosis. , 1997, Journal of hepatology.

[49]  R. Rodrigo,et al.  Oxidative stress-related parameters in the liver of non-alcoholic fatty liver disease patients. , 2004, Clinical science.

[50]  A. McCullough,et al.  The clinical features, diagnosis and natural history of nonalcoholic fatty liver disease. , 2004, Clinics in liver disease.

[51]  F. Anania,et al.  Abnormal lipid and glucose metabolism in obesity: implications for nonalcoholic fatty liver disease. , 2007, Gastroenterology.

[52]  J. Clore,et al.  Nonalcoholic steatohepatitis: association of insulin resistance and mitochondrial abnormalities. , 2001, Gastroenterology.

[53]  S. Kahn,et al.  Insulin Transport From Plasma Into the Central Nervous System Is Inhibited by Dexamethasone in Dogs , 1996, Diabetes.

[54]  L. Kappelle,et al.  Increased risk of Alzheimer's disease in Type II diabetes: insulin resistance of the brain or insulin-induced amyloid pathology? , 2005, Biochemical Society transactions.

[55]  M. Ingelman-Sundberg,et al.  Hepatic cytochrome P450 2E1 is increased in patients with nonalcoholic steatohepatitis , 1998, Hepatology.

[56]  D. Pessayre,et al.  Ethanol increases mitochondrial cytochrome P450 2E1 in mouse liver and rat hepatocytes , 2005 .

[57]  Suzanne Craft,et al.  Insulin and neurodegenerative disease: shared and specific mechanisms , 2004, The Lancet Neurology.

[58]  M. Reveley,et al.  Human platelet monoamine oxidase activity in health and disease: a review. , 1981, Journal of clinical pathology.

[59]  D. Ghareeb,et al.  Ameliorated effects of garlic (Allium sativum) on biomarkers of subchronic acrylamide hepatotoxicity and brain toxicity in rats , 2010 .

[60]  G. Shulman,et al.  Inhibition of protein kinase Cε prevents hepatic insulin resistance in nonalcoholic fatty liver disease , 2007 .

[61]  D. Alkon,et al.  Role of insulin and insulin receptor in learning and memory , 2001, Molecular and Cellular Endocrinology.

[62]  S. Craft,et al.  Insulin resistance, inflammation, and cognition in Alzheimer's Disease: Lessons for multiple sclerosis , 2006, Journal of the Neurological Sciences.

[63]  J. Horton,et al.  Molecular mediators of hepatic steatosis and liver injury. , 2004, The Journal of clinical investigation.

[64]  R. Butterworth,et al.  The neurosteroid system: Implication in the pathophysiology of hepatic encephalopathy , 2008, Neurochemistry International.

[65]  D. Pessayre,et al.  Nonalcoholic steatosis and steatohepatitis. V. Mitochondrial dysfunction in steatohepatitis. , 2002, American journal of physiology. Gastrointestinal and liver physiology.

[66]  P. Marsden,et al.  The role of insulin in human brain glucose metabolism: an 18fluoro-deoxyglucose positron emission tomography study. , 2002, Diabetes.

[67]  J. McGarry.  Banting lecture 2001: dysregulation of fatty acid metabolism in the etiology of type 2 diabetes. , 2002, Diabetes.

[68]  J. McGarry,et al.  Fatty acids, lipotoxicity and insulin secretion , 1999, Diabetologia.

[69]  K. Mak,et al.  Cytochrome P4502E1 primes macrophages to increase TNF-alpha production in response to lipopolysaccharide. , 2005, American journal of physiology. Gastrointestinal and liver physiology.

[70]  E. P. Dellinger,et al.  CYP2E1 activity before and after weight loss in morbidly obese subjects with nonalcoholic fatty liver disease , 2003, Hepatology.

[71]  Robert P. Wilson,et al.  Amino acids and proteins , 2003 .

[72]  D. D. de Luis,et al.  Effect of a hypocaloric diet in transaminases in nonalcoholic fatty liver disease and obese patients, relation with insulin resistance. , 2008, Diabetes research and clinical practice.

[73]  S. Brimijoin,et al.  Amyloid‐beta increases acetylcholinesterase expression in neuroblastoma cells by reducing enzyme degradation , 2003, Journal of neurochemistry.

[74]  Sylvain Houle,et al.  Elevated monoamine oxidase a levels in the brain: an explanation for the monoamine imbalance of major depression. , 2006, Archives of general psychiatry.

[75]  G. Farrell,et al.  Nonalcoholic fatty liver disease: From steatosis to cirrhosis , 2006, Hepatology.

[76]  E. Wills.  Mechanisms of lipid peroxide formation in animal tissues. , 1966, The Biochemical journal.

[77]  P. Ward,et al.  Lipid peroxidation in hepatic steatosis in humans is associated with hepatic fibrosis and occurs predominately in acinar zone 3 , 2001, Journal of gastroenterology and hepatology.

[78]  K. Courtney,et al.  A new and rapid colorimetric determination of acetylcholinesterase activity. , 1961, Biochemical pharmacology.

[79]  D. Ghareeb,et al.  Toxic effects of lead exposure on the brain of rats: Involvement of oxidative stress, inflammation, acetylcholinesterase, and the beneficial role of flaxseed extract , 2010 .

[80]  D. Ghareeb,et al.  Vanadium improves brain acetylcholinesterase activity on early stage alloxan-diabetic rats , 2008, Neuroscience Letters.

[81]  S. Shoelson,et al.  Local and systemic insulin resistance resulting from hepatic activation of IKK-β and NF-κB , 2005, Nature Medicine.

[82]  B. Neuschwander‐Tetri,et al.  Interim results of a pilot study demonstrating the early effects of the PPAR-gamma ligand rosiglitazone on insulin sensitivity, aminotransferases, hepatic steatosis and body weight in patients with non-alcoholic steatohepatitis. , 2003, Journal of hepatology.

[83]  P. Angulo.  GI Epidemiology: nonalcoholic fatty liver disease , 2007, Alimentary pharmacology & therapeutics.

[84]  D. Rathore,et al.  A Rapid Spectrophotometric Method for the Determination of Nitrite in Water. , 1990 .

[85]  J. Noble,et al.  INTRANASAL INSULIN IMPROVES COGNITION AND MODULATES β-AMYLOID IN EARLY AD , 2009, Neurology.

[86]  M. Taniai,et al.  Influence of TNF gene polymorphisms in Japanese patients with NASH and simple steatosis. , 2007, Journal of hepatology.

[87]  N. Volkow,et al.  Neuropharmacological actions of cigarette smoke: brain monoamine oxidase B (MAO B) inhibition. , 1998, Journal of addictive diseases.

[88]  H. Minuk,et al.  Metabolic syndrome. , 2005, Journal of insurance medicine.

[89]  William A Banks,et al.  The source of cerebral insulin. , 2004, European journal of pharmacology.

[90]  S. Shimohama,et al.  Cl−-ATPase and Na+/K+-ATPase activities in Alzheimer's disease brains , 1998, Neuroscience Letters.

[91]  J. Newcomer,et al.  Enhancement of memory in Alzheimer disease with insulin and somatostatin, but not glucose. , 1999, Archives of general psychiatry.

[92]  N. Barzilai,et al.  Increased intrahepatic triglyceride is associated with peripheral insulin resistance: in vivo MR imaging and spectroscopy studies. , 2007, American journal of physiology. Endocrinology and metabolism.

[93]  J. Schildkraut,et al.  Reduced platelet monoamine oxidase activity in a subgroup of schizophrenic patients. , 1976, The American journal of psychiatry.

[94]  K. Petersen,et al.  Reversal of nonalcoholic hepatic steatosis, hepatic insulin resistance, and hyperglycemia by moderate weight reduction in patients with type 2 diabetes. , 2005, Diabetes.

[95]  M. Hjelm,et al.  A METHODOLOGICAL STUDY OF THE ENZYMATIC DETERMINATION OF GLUCOSE IN BLOOD. , 1963, Scandinavian journal of clinical and laboratory investigation.

[96]  V. Calabrese,et al.  Mitochondrial Involvement in Brain Function and Dysfunction: Relevance to Aging, Neurodegenerative Disorders and Longevity , 2001, Neurochemical Research.

[97]  J. Sastre,et al.  Mitochondrial involvement in non-alcoholic steatohepatitis. , 2008, Molecular aspects of medicine.